RE:RE:RE:RE:RE:2022 was a disaster for the longs and 2023 could be worse.Yeah. I happen to have done enough research to know a lot of Sixth Wave's problems are not actually their direct doing but because partners had difficulty - Barry-hollinger mine dissolved in November 2022, Rio2 got tanked by the Chilean government, Green Envy (Read my research post on Affinity) is as far as I can see a barely functional business with little web presence and it seems like one of their subsidiaries lost a court case and owes a lot of money to someone.
But then they are partnered with U of A, York, their AMIP in air monitoring research is being overseen by the federal government along with their partner BluMetric (which is a *gasp* profitable small-cap), and their partner MPS and their glyleach/glycat systems are definitely legitimate, promising and being examined by large established companies in the mining space.
I mean, look. I get it. Sixth Wave has the air of a company that is a typical CSE P&D (which IMO is like 90% of companies on the CSE and at least half on the TSXV period). They pursue topical things, covid, weed. They have a bunch of interviews on paid-for stock coverage sites. Their stock sucks and is down almost 100%. The CEO is still taking >$200k per year while this happens.
And for the most part, I agree with you, they need to act in accordance with a way that suggests -they believe the company will succeed-, rather than giving us the impression they're a rich guy on the Titanic trying to drink all the Cognac before it sinks.
I just want to point out that much - and I mean one substantial hell of a lot - that has gone wrong here was out of the company's own hands.
BadenBaden wrote: My concern is that their attention seemed currently focused on the growing trend of viruses (the continuous chase, as you might call it). That's what they've been feeding us with. What investors would like to hear is for management to get a working product commercially available. Up to this point, we've only heard about them engaged a company work on prototype and that's about it. We already know it can detect variants, salmonella..etc. etc.. No update about a working product up for approval in CA or US for commercial use. IXOS is a different beast though I must admit and is a separate topic. It is the only one I think up to this point, that has the potential.
My 2 cents....Nobody will invest if the CEO keeps on making empty promises. The internet NEVER forgets. All videos released were just the very same old script. The only thing new about it is that he's wearing a different shirt or someone else interviewing him.
@ 0.89/share ATH I thought that this is the stock to watch. The potential alone should give this at least $5 (or more /share), make resounding entry to CSE and out of the venture market. A new leadership is definitely needed. Need a different mindset or perhaps a change in business model.
They dropped the ball big time >>>>. .89 to .035 .
I hope I am wrong and would like to think I'm wrong